Entries by Regula Inspection Services

Turkish ‘BloodStopper’ drug ready for export

Turkey has long-sought to heal wounds in conflict zones around the world, and with a new locally-produced drug, Ankaferd BloodStopper, it will now be able to do just that. Ankaferd BloodStopper is a coagulant agent touted as Turkey’s first fully domestic medicine.

BMS completes $74B Celgene Acquisition

Bristol-Myers Squibb has finalized its $74 billion acquisition of Celgene Corp., forming an even larger biopharmaceuticals giant, the company announced Wednesday. Regulators signed off on the transaction, which was first announced in January, after Celgene agreed  in August to sell its psoriasis drug Otezla to Amgen for $13.4 billion. 

Standard Operating Procedures

The Standard Operating Procedures (SOPs) have a detailed description level. It has been said that they should be written so that you could take any person from the street and that person would be able do the correct thing by following the SOP.

Internal GMP Audits

If you were the chief executive officer of a successful pharmaceutical company would you want to know that your company was meeting and exceeding customer expectations? Do you know who your customers are?

Merck to lay off 500 workers around the U.S.

Merck, like many of its Big Pharma peers, is working to focus more on innovative drugs. But as part of that ongoing shift, the company is eliminating 500 positions nationwide.

Johnson & Johnson recalls…

J&J, which is facing thousands of lawsuits from people who claim its talc products caused cancer, said it had initiated the voluntary recall of one lot of baby powder, produced and shipped in the US in 2018, out of “an abundance of caution”.